| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |